MyxoBiomedical
PrivateTotal Funding Raised
$1M
Company Overview
MyxoBiomedical operates in Healthcare & Life Sciences and is based in Germany. It has raised $1M.
MyxoBiomedical is a biotechnology company that develops resistance-breaking macrolide antibiotics based on the myxobacterial natural product scaffold chlorotonil for the treatment of MRSA and VRE infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyxoBiomedical Comparables
Compare MyxoBiomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 88% | |
| Macrolide Pharmaceuticals | 87% | |
| APY Therapeutics | 85% |
For institutional investors. Book with your work email.
MyxoBiomedical Funding Rounds
Historical fundraising activity
MyxoBiomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
MyxoBiomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MyxoBiomedical's valuation, stock price, and market status.
Is MyxoBiomedical a public or private company?
MyxoBiomedical is a private company.
What is the current stock price of MyxoBiomedical?
MyxoBiomedical is a private company, so its shares have no public market price. Caplight tracks MyxoBiomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MyxoBiomedical worth (valuation)?
Valuation information for MyxoBiomedical is not publicly available.
Can I buy MyxoBiomedical stock?
MyxoBiomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MyxoBiomedical's last funding round?
Funding round information for MyxoBiomedical is not publicly available.
Who are the main investors in MyxoBiomedical?
Key investors in MyxoBiomedical include National Cancer Institute.
Will MyxoBiomedical IPO soon?
No public IPO plans have been announced for MyxoBiomedical.
How can I track MyxoBiomedical secondary market activity?
Caplight tracks bids, offers, and trades in MyxoBiomedical's shares on secondary markets.